Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nitroglycerin | 12 | 2011 | 329 | 2.060 |
Why?
|
Vasodilator Agents | 15 | 2011 | 978 | 1.470 |
Why?
|
Cardiac Pacing, Artificial | 15 | 2009 | 866 | 1.210 |
Why?
|
Sympathetic Nervous System | 8 | 2012 | 520 | 1.190 |
Why?
|
Endothelium, Vascular | 15 | 2012 | 4433 | 1.090 |
Why?
|
Vasodilation | 11 | 2011 | 962 | 1.090 |
Why?
|
Drug Tolerance | 8 | 2011 | 369 | 1.040 |
Why?
|
Angina Pectoris | 9 | 2009 | 969 | 0.770 |
Why?
|
Nitrates | 6 | 2009 | 264 | 0.750 |
Why?
|
Heart Failure | 26 | 2012 | 11847 | 0.700 |
Why?
|
Brachial Artery | 2 | 2011 | 366 | 0.640 |
Why?
|
Inclusion Bodies, Viral | 5 | 2004 | 45 | 0.570 |
Why?
|
Heart | 27 | 2012 | 4393 | 0.540 |
Why?
|
Reoviridae | 5 | 2004 | 162 | 0.530 |
Why?
|
Ventricular Function, Left | 13 | 2012 | 3880 | 0.530 |
Why?
|
Hemodynamics | 19 | 2012 | 4174 | 0.530 |
Why?
|
Isosorbide Dinitrate | 2 | 2007 | 37 | 0.520 |
Why?
|
Norepinephrine | 5 | 2012 | 900 | 0.520 |
Why?
|
Radionuclide Imaging | 45 | 2021 | 1975 | 0.520 |
Why?
|
Nuclear Medicine | 5 | 2003 | 236 | 0.520 |
Why?
|
Dobutamine | 2 | 2008 | 116 | 0.500 |
Why?
|
Myocardial Reperfusion Injury | 2 | 2010 | 479 | 0.460 |
Why?
|
Adrenergic beta-Agonists | 2 | 2008 | 345 | 0.450 |
Why?
|
Ventricular Dysfunction, Left | 7 | 2012 | 2128 | 0.450 |
Why?
|
Cardiomyopathy, Dilated | 4 | 2009 | 819 | 0.440 |
Why?
|
Ischemic Preconditioning, Myocardial | 3 | 2010 | 69 | 0.420 |
Why?
|
Coronary Disease | 19 | 2011 | 5990 | 0.410 |
Why?
|
Coronary Circulation | 10 | 2012 | 1577 | 0.400 |
Why?
|
Nitric Oxide Synthase | 3 | 2010 | 908 | 0.370 |
Why?
|
omega-N-Methylarginine | 1 | 2010 | 108 | 0.370 |
Why?
|
Pulmonary Embolism | 13 | 2001 | 2543 | 0.360 |
Why?
|
Folic Acid | 2 | 2010 | 1309 | 0.360 |
Why?
|
Acetylcholine | 2 | 2010 | 629 | 0.350 |
Why?
|
Radial Artery | 2 | 2010 | 196 | 0.350 |
Why?
|
Free Radicals | 3 | 2009 | 238 | 0.350 |
Why?
|
Piperazines | 5 | 2007 | 2525 | 0.340 |
Why?
|
Metoprolol | 2 | 2011 | 92 | 0.330 |
Why?
|
Propanolamines | 2 | 2011 | 162 | 0.330 |
Why?
|
Myocardial Ischemia | 8 | 2011 | 2164 | 0.320 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 11 | 2009 | 1067 | 0.320 |
Why?
|
Heptanoic Acids | 1 | 2011 | 347 | 0.320 |
Why?
|
Nitro Compounds | 1 | 2008 | 74 | 0.310 |
Why?
|
Vitamin B Complex | 1 | 2010 | 297 | 0.310 |
Why?
|
Carbazoles | 2 | 2011 | 220 | 0.310 |
Why?
|
Double-Blind Method | 18 | 2011 | 12427 | 0.300 |
Why?
|
Fluorobenzenes | 1 | 2010 | 180 | 0.300 |
Why?
|
Sulfones | 3 | 2007 | 447 | 0.300 |
Why?
|
Virus Assembly | 4 | 2004 | 139 | 0.300 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2010 | 321 | 0.300 |
Why?
|
Forearm | 3 | 2010 | 429 | 0.300 |
Why?
|
Organometallic Compounds | 5 | 2021 | 662 | 0.300 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2010 | 704 | 0.290 |
Why?
|
Cyclooxygenase 2 | 1 | 2010 | 599 | 0.290 |
Why?
|
Heart Rate | 13 | 2011 | 4179 | 0.290 |
Why?
|
Viral Proteins | 6 | 2004 | 1802 | 0.290 |
Why?
|
Regional Blood Flow | 7 | 2010 | 1490 | 0.280 |
Why?
|
Nitroprusside | 3 | 2004 | 273 | 0.280 |
Why?
|
Diuretics | 2 | 2007 | 613 | 0.280 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2007 | 214 | 0.270 |
Why?
|
Kidney | 3 | 2008 | 7064 | 0.260 |
Why?
|
Blood Pressure | 18 | 2012 | 8525 | 0.260 |
Why?
|
Viral Core Proteins | 4 | 2004 | 161 | 0.260 |
Why?
|
Viral Nonstructural Proteins | 3 | 2004 | 223 | 0.260 |
Why?
|
Phlebography | 2 | 2006 | 325 | 0.260 |
Why?
|
Nuclear Medicine Department, Hospital | 3 | 2003 | 13 | 0.260 |
Why?
|
Atrioventricular Node | 1 | 2006 | 180 | 0.250 |
Why?
|
Thallium | 8 | 2003 | 100 | 0.250 |
Why?
|
Hypertension, Pulmonary | 2 | 2012 | 1570 | 0.250 |
Why?
|
Cardiac Output | 8 | 2012 | 838 | 0.250 |
Why?
|
Endothelins | 1 | 2005 | 127 | 0.240 |
Why?
|
Coronary Angiography | 10 | 2011 | 4563 | 0.240 |
Why?
|
Pyrroles | 1 | 2011 | 1137 | 0.230 |
Why?
|
Sulfonamides | 2 | 2014 | 1977 | 0.230 |
Why?
|
Pressoreceptors | 1 | 2004 | 100 | 0.230 |
Why?
|
Nitric Oxide Donors | 1 | 2004 | 125 | 0.230 |
Why?
|
Reflex, Abnormal | 1 | 2004 | 83 | 0.230 |
Why?
|
Tissue Plasminogen Activator | 7 | 1997 | 1190 | 0.230 |
Why?
|
Elasticity Imaging Techniques | 1 | 2009 | 388 | 0.230 |
Why?
|
Vasoconstriction | 4 | 2011 | 593 | 0.230 |
Why?
|
Pentaerythritol Tetranitrate | 1 | 2003 | 2 | 0.230 |
Why?
|
Myocardium | 7 | 2010 | 4700 | 0.220 |
Why?
|
Ventilation-Perfusion Ratio | 2 | 2001 | 117 | 0.220 |
Why?
|
Telecommunications | 1 | 2003 | 80 | 0.220 |
Why?
|
Yttrium Radioisotopes | 1 | 2024 | 107 | 0.220 |
Why?
|
Exercise Tolerance | 2 | 2007 | 830 | 0.220 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2009 | 1259 | 0.220 |
Why?
|
Coronary Artery Disease | 7 | 2012 | 6659 | 0.210 |
Why?
|
Cardiotonic Agents | 2 | 2005 | 546 | 0.210 |
Why?
|
Technetium | 13 | 2003 | 321 | 0.210 |
Why?
|
Thrombolytic Therapy | 7 | 1997 | 2108 | 0.200 |
Why?
|
Diastole | 5 | 2003 | 788 | 0.200 |
Why?
|
Baroreflex | 1 | 2002 | 148 | 0.200 |
Why?
|
Meglumine | 4 | 2006 | 145 | 0.190 |
Why?
|
Hyperaldosteronism | 1 | 2004 | 244 | 0.190 |
Why?
|
Microspheres | 1 | 2024 | 787 | 0.180 |
Why?
|
Humans | 148 | 2024 | 760621 | 0.180 |
Why?
|
Endothelium | 1 | 2003 | 764 | 0.180 |
Why?
|
Internet | 2 | 2003 | 3078 | 0.180 |
Why?
|
Computer Communication Networks | 3 | 1998 | 294 | 0.180 |
Why?
|
Radioisotopes | 9 | 1987 | 495 | 0.180 |
Why?
|
Middle Aged | 74 | 2024 | 220352 | 0.180 |
Why?
|
Heart Ventricles | 10 | 2006 | 3811 | 0.180 |
Why?
|
Echocardiography | 12 | 2009 | 4981 | 0.180 |
Why?
|
Hypertension | 6 | 2010 | 8594 | 0.170 |
Why?
|
Arginine | 2 | 2011 | 934 | 0.170 |
Why?
|
Radiology Information Systems | 2 | 2003 | 528 | 0.170 |
Why?
|
Pyrazoles | 1 | 2010 | 1999 | 0.170 |
Why?
|
Male | 89 | 2024 | 359744 | 0.170 |
Why?
|
Thallium Radioisotopes | 5 | 2002 | 138 | 0.170 |
Why?
|
Exercise Test | 15 | 2007 | 2128 | 0.160 |
Why?
|
Infusions, Intravenous | 5 | 2008 | 2234 | 0.160 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2011 | 3334 | 0.150 |
Why?
|
Microtubules | 3 | 2004 | 1072 | 0.150 |
Why?
|
Enzyme Inhibitors | 4 | 2012 | 3726 | 0.150 |
Why?
|
Lung | 9 | 2003 | 9994 | 0.150 |
Why?
|
Tomography, Emission-Computed | 4 | 2001 | 1121 | 0.150 |
Why?
|
Virion | 3 | 2004 | 421 | 0.150 |
Why?
|
Pyrimidines | 1 | 2010 | 3016 | 0.150 |
Why?
|
Liver Neoplasms | 3 | 2024 | 4319 | 0.140 |
Why?
|
Reference Values | 6 | 2011 | 4925 | 0.140 |
Why?
|
Electrocardiography | 16 | 2007 | 6414 | 0.140 |
Why?
|
Capsid Proteins | 3 | 2004 | 467 | 0.140 |
Why?
|
Sleep Apnea Syndromes | 4 | 2003 | 974 | 0.140 |
Why?
|
Indium Radioisotopes | 2 | 1993 | 113 | 0.140 |
Why?
|
Antioxidants | 1 | 2004 | 1667 | 0.130 |
Why?
|
Telemedicine | 2 | 2003 | 3018 | 0.130 |
Why?
|
Fuzzy Logic | 1 | 1995 | 57 | 0.130 |
Why?
|
Urokinase-Type Plasminogen Activator | 4 | 1997 | 326 | 0.130 |
Why?
|
Neuroendocrine Tumors | 1 | 2021 | 650 | 0.120 |
Why?
|
Adult | 53 | 2012 | 219994 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2008 | 10827 | 0.120 |
Why?
|
Indoles | 2 | 2014 | 1829 | 0.120 |
Why?
|
Aged | 52 | 2024 | 169152 | 0.120 |
Why?
|
Cross-Over Studies | 3 | 2007 | 2061 | 0.120 |
Why?
|
Joints | 2 | 1993 | 321 | 0.120 |
Why?
|
Purines | 3 | 2007 | 605 | 0.120 |
Why?
|
Physical Exertion | 3 | 2004 | 662 | 0.120 |
Why?
|
Hemangiopericytoma | 1 | 2014 | 71 | 0.120 |
Why?
|
Orthoreovirus, Mammalian | 2 | 2004 | 40 | 0.110 |
Why?
|
Renal Circulation | 2 | 2005 | 291 | 0.110 |
Why?
|
Energy Metabolism | 1 | 2005 | 2869 | 0.110 |
Why?
|
Sleep Apnea, Obstructive | 4 | 2009 | 1860 | 0.110 |
Why?
|
Female | 71 | 2024 | 391270 | 0.110 |
Why?
|
Pulmonary Circulation | 4 | 1993 | 743 | 0.110 |
Why?
|
Smoking | 1 | 2010 | 9073 | 0.110 |
Why?
|
Nitric Oxide | 3 | 2012 | 2141 | 0.110 |
Why?
|
Teleradiology | 2 | 2003 | 53 | 0.110 |
Why?
|
Sleep, REM | 1 | 1996 | 593 | 0.110 |
Why?
|
Stroke Volume | 11 | 2011 | 5523 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2003 | 3340 | 0.100 |
Why?
|
Heart Failure, Systolic | 2 | 2011 | 136 | 0.100 |
Why?
|
Phospholipases A2, Secretory | 1 | 2012 | 30 | 0.100 |
Why?
|
Synovitis | 1 | 1993 | 215 | 0.100 |
Why?
|
Radiopharmaceuticals | 5 | 2003 | 2634 | 0.100 |
Why?
|
Emergency Medical Services | 1 | 2003 | 1925 | 0.100 |
Why?
|
Heart Diseases | 8 | 2010 | 2809 | 0.100 |
Why?
|
Pericytes | 1 | 2014 | 293 | 0.100 |
Why?
|
Retinal Drusen | 1 | 2012 | 74 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2024 | 2299 | 0.100 |
Why?
|
Autonomic Nervous System Diseases | 2 | 2010 | 269 | 0.100 |
Why?
|
Adrenergic beta-1 Receptor Antagonists | 1 | 2011 | 30 | 0.100 |
Why?
|
Fluorescein | 1 | 2012 | 174 | 0.100 |
Why?
|
Cardiovascular Diseases | 3 | 2008 | 15757 | 0.090 |
Why?
|
Peroneal Nerve | 1 | 2011 | 76 | 0.090 |
Why?
|
Models, Cardiovascular | 2 | 2010 | 978 | 0.090 |
Why?
|
Drug Administration Routes | 1 | 2011 | 150 | 0.090 |
Why?
|
Injections, Intradermal | 1 | 2010 | 116 | 0.090 |
Why?
|
Nocturnal Myoclonus Syndrome | 1 | 2011 | 51 | 0.090 |
Why?
|
Tetrazoles | 2 | 2007 | 905 | 0.090 |
Why?
|
Hemorheology | 1 | 2011 | 144 | 0.090 |
Why?
|
Administration, Cutaneous | 2 | 2003 | 713 | 0.090 |
Why?
|
Acetates | 1 | 2012 | 321 | 0.090 |
Why?
|
Reactive Oxygen Species | 3 | 2009 | 2138 | 0.090 |
Why?
|
Teaching | 1 | 1998 | 1169 | 0.090 |
Why?
|
Analysis of Variance | 3 | 2010 | 6238 | 0.090 |
Why?
|
Oxidative Stress | 3 | 2011 | 3106 | 0.090 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2010 | 260 | 0.090 |
Why?
|
Heparin | 3 | 1997 | 1652 | 0.090 |
Why?
|
Pulmonary Wedge Pressure | 3 | 2007 | 273 | 0.090 |
Why?
|
Vasomotor System | 1 | 2010 | 207 | 0.090 |
Why?
|
Periodicity | 1 | 2011 | 348 | 0.080 |
Why?
|
Premedication | 1 | 2010 | 253 | 0.080 |
Why?
|
Spleen | 1 | 1995 | 2298 | 0.080 |
Why?
|
Myocardial Contraction | 7 | 2002 | 1516 | 0.080 |
Why?
|
Diltiazem | 2 | 2004 | 131 | 0.080 |
Why?
|
Sodium Pertechnetate Tc 99m | 2 | 1987 | 55 | 0.080 |
Why?
|
Renal Plasma Flow | 1 | 2008 | 27 | 0.080 |
Why?
|
Contrast Media | 4 | 2006 | 5305 | 0.080 |
Why?
|
Sleep Apnea, Central | 1 | 2009 | 88 | 0.070 |
Why?
|
Treatment Outcome | 13 | 2024 | 65017 | 0.070 |
Why?
|
Time Factors | 19 | 2011 | 40165 | 0.070 |
Why?
|
Parathyroid Neoplasms | 1 | 2009 | 241 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2001 | 2007 | 0.070 |
Why?
|
Blood Flow Velocity | 2 | 2011 | 1377 | 0.070 |
Why?
|
Meckel Diverticulum | 1 | 1987 | 32 | 0.070 |
Why?
|
Fluconazole | 1 | 2008 | 155 | 0.070 |
Why?
|
Gravitation | 1 | 1987 | 82 | 0.070 |
Why?
|
Amiloride | 1 | 2007 | 116 | 0.070 |
Why?
|
Adolescent | 11 | 2011 | 87810 | 0.070 |
Why?
|
Erythrocytes | 6 | 1987 | 2415 | 0.070 |
Why?
|
Hydrochlorothiazide | 1 | 2007 | 94 | 0.070 |
Why?
|
Thyroid Neoplasms | 2 | 2014 | 2332 | 0.070 |
Why?
|
Observer Variation | 3 | 2012 | 2601 | 0.070 |
Why?
|
Patients | 1 | 1993 | 906 | 0.070 |
Why?
|
Coronary Vessels | 6 | 2012 | 3112 | 0.070 |
Why?
|
Drug Administration Schedule | 2 | 2007 | 4899 | 0.070 |
Why?
|
Microscopy, Fluorescence | 2 | 2004 | 2651 | 0.070 |
Why?
|
Microvessels | 1 | 2011 | 572 | 0.070 |
Why?
|
Blood Circulation | 1 | 2007 | 249 | 0.070 |
Why?
|
Movement | 1 | 1993 | 1474 | 0.070 |
Why?
|
Radiography | 6 | 2008 | 6965 | 0.070 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2010 | 516 | 0.070 |
Why?
|
Cardiac Output, Low | 1 | 2006 | 192 | 0.060 |
Why?
|
Fluorescent Dyes | 2 | 2012 | 1913 | 0.060 |
Why?
|
Autonomic Nervous System | 3 | 2003 | 697 | 0.060 |
Why?
|
Liver | 3 | 2002 | 7509 | 0.060 |
Why?
|
Ventricular Function, Right | 2 | 2003 | 610 | 0.060 |
Why?
|
Administration, Oral | 3 | 2003 | 4035 | 0.060 |
Why?
|
Thymus Hyperplasia | 1 | 2005 | 32 | 0.060 |
Why?
|
Orthoreovirus | 1 | 2004 | 22 | 0.060 |
Why?
|
Myristic Acids | 1 | 2004 | 49 | 0.060 |
Why?
|
Streptokinase | 1 | 1985 | 187 | 0.060 |
Why?
|
Creatinine | 1 | 2010 | 1903 | 0.060 |
Why?
|
Sensitivity and Specificity | 7 | 2011 | 14660 | 0.060 |
Why?
|
Physical Endurance | 1 | 2007 | 363 | 0.060 |
Why?
|
Ontario | 3 | 2011 | 404 | 0.060 |
Why?
|
Pyridines | 2 | 2007 | 2879 | 0.060 |
Why?
|
Acute Disease | 6 | 2007 | 7269 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 2053 | 0.060 |
Why?
|
Lactates | 1 | 2005 | 404 | 0.060 |
Why?
|
Calcium Channel Blockers | 2 | 2007 | 694 | 0.060 |
Why?
|
Glyburide | 1 | 2005 | 114 | 0.060 |
Why?
|
Furosemide | 1 | 2005 | 170 | 0.060 |
Why?
|
Macular Degeneration | 1 | 2012 | 1002 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2012 | 1880 | 0.060 |
Why?
|
Echocardiography, Doppler | 3 | 2006 | 901 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2014 | 2049 | 0.060 |
Why?
|
Nucleoside-Triphosphatase | 1 | 2003 | 19 | 0.060 |
Why?
|
Renal Veins | 1 | 2004 | 102 | 0.060 |
Why?
|
Acid Anhydride Hydrolases | 1 | 2003 | 66 | 0.060 |
Why?
|
Jugular Veins | 1 | 2005 | 211 | 0.060 |
Why?
|
Metabolic Clearance Rate | 1 | 2004 | 361 | 0.060 |
Why?
|
Cholesterol, HDL | 1 | 2010 | 1817 | 0.060 |
Why?
|
Amlodipine | 1 | 2004 | 84 | 0.060 |
Why?
|
Atenolol | 1 | 2004 | 99 | 0.060 |
Why?
|
Body Water | 1 | 1985 | 341 | 0.060 |
Why?
|
Ascorbic Acid | 1 | 2007 | 655 | 0.060 |
Why?
|
Chest Pain | 1 | 2011 | 1106 | 0.060 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2005 | 393 | 0.060 |
Why?
|
Coronary Artery Bypass | 2 | 2003 | 2272 | 0.050 |
Why?
|
Plasma Volume | 1 | 2002 | 31 | 0.050 |
Why?
|
Peroxynitrous Acid | 1 | 2002 | 42 | 0.050 |
Why?
|
Oxygen | 2 | 2010 | 4193 | 0.050 |
Why?
|
Drug Therapy, Combination | 3 | 2011 | 6498 | 0.050 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2006 | 277 | 0.050 |
Why?
|
Biotransformation | 1 | 2002 | 166 | 0.050 |
Why?
|
Drug Interactions | 1 | 2007 | 1428 | 0.050 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2006 | 488 | 0.050 |
Why?
|
Computers | 7 | 1983 | 595 | 0.050 |
Why?
|
Prodrugs | 1 | 2004 | 259 | 0.050 |
Why?
|
Clonidine | 1 | 2003 | 170 | 0.050 |
Why?
|
Withholding Treatment | 1 | 2006 | 613 | 0.050 |
Why?
|
Ventricular Pressure | 1 | 2003 | 204 | 0.050 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2005 | 615 | 0.050 |
Why?
|
Parasympathetic Nervous System | 1 | 2002 | 141 | 0.050 |
Why?
|
Microscopy, Immunoelectron | 1 | 2002 | 317 | 0.050 |
Why?
|
Potassium Channels | 1 | 2005 | 534 | 0.050 |
Why?
|
Cell Line | 4 | 2004 | 15620 | 0.050 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2007 | 577 | 0.050 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2010 | 1717 | 0.050 |
Why?
|
Cricetinae | 2 | 2002 | 2427 | 0.050 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2006 | 452 | 0.050 |
Why?
|
Systems Integration | 1 | 2003 | 426 | 0.050 |
Why?
|
Gallium Radioisotopes | 2 | 2021 | 195 | 0.050 |
Why?
|
Superoxides | 1 | 2002 | 387 | 0.050 |
Why?
|
Aged, 80 and over | 14 | 2012 | 58995 | 0.050 |
Why?
|
Specialty Boards | 1 | 2003 | 235 | 0.050 |
Why?
|
Hospital Departments | 3 | 1990 | 136 | 0.050 |
Why?
|
Erectile Dysfunction | 1 | 2005 | 452 | 0.050 |
Why?
|
Remote Consultation | 1 | 2003 | 234 | 0.050 |
Why?
|
Polysomnography | 4 | 2011 | 1825 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2010 | 2420 | 0.050 |
Why?
|
Placebo Effect | 1 | 2005 | 520 | 0.050 |
Why?
|
Arthritis, Rheumatoid | 2 | 1993 | 3763 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2024 | 80372 | 0.040 |
Why?
|
Vascular Patency | 1 | 2003 | 901 | 0.040 |
Why?
|
Gadolinium DTPA | 2 | 2002 | 823 | 0.040 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2006 | 854 | 0.040 |
Why?
|
Liver Diseases | 2 | 2002 | 1302 | 0.040 |
Why?
|
Ventricular Function | 3 | 2011 | 408 | 0.040 |
Why?
|
Saphenous Vein | 1 | 2003 | 537 | 0.040 |
Why?
|
Myocardial Stunning | 1 | 2000 | 66 | 0.040 |
Why?
|
Vascular Resistance | 4 | 2011 | 933 | 0.040 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2000 | 131 | 0.040 |
Why?
|
Animals | 17 | 2009 | 167963 | 0.040 |
Why?
|
Transfection | 3 | 2003 | 5781 | 0.040 |
Why?
|
Chronic Disease | 4 | 2007 | 9287 | 0.040 |
Why?
|
Selection Bias | 1 | 2002 | 358 | 0.040 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2002 | 590 | 0.040 |
Why?
|
Device Removal | 1 | 2005 | 636 | 0.040 |
Why?
|
Body Mass Index | 5 | 2010 | 12914 | 0.040 |
Why?
|
Posture | 2 | 2003 | 953 | 0.040 |
Why?
|
Muscles | 1 | 1985 | 1581 | 0.040 |
Why?
|
Oxygen Consumption | 2 | 2005 | 1843 | 0.040 |
Why?
|
Glomerular Filtration Rate | 1 | 2008 | 2180 | 0.040 |
Why?
|
Ubiquitin | 1 | 2004 | 838 | 0.040 |
Why?
|
Sex Factors | 2 | 2010 | 10547 | 0.040 |
Why?
|
Data Collection | 1 | 1989 | 3315 | 0.040 |
Why?
|
Software | 4 | 2002 | 4419 | 0.040 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 2 | 1990 | 66 | 0.040 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2003 | 733 | 0.040 |
Why?
|
Protein Conformation | 2 | 2004 | 3969 | 0.040 |
Why?
|
Vascular Neoplasms | 1 | 2000 | 167 | 0.040 |
Why?
|
Reference Books | 1 | 1998 | 2 | 0.040 |
Why?
|
Myocardial Infarction | 6 | 2009 | 11891 | 0.040 |
Why?
|
Ultrasonography | 3 | 2008 | 5961 | 0.040 |
Why?
|
CD-ROM | 1 | 1998 | 24 | 0.040 |
Why?
|
Veins | 1 | 2003 | 765 | 0.040 |
Why?
|
Thromboembolism | 1 | 2005 | 1017 | 0.040 |
Why?
|
Likelihood Functions | 1 | 2001 | 987 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2004 | 2222 | 0.040 |
Why?
|
Cause of Death | 2 | 2007 | 3725 | 0.040 |
Why?
|
Hypotension | 2 | 1995 | 883 | 0.040 |
Why?
|
Recombinant Proteins | 4 | 2003 | 6538 | 0.040 |
Why?
|
Microcomputers | 1 | 1998 | 141 | 0.040 |
Why?
|
Arteries | 1 | 2003 | 1126 | 0.040 |
Why?
|
Cardiovascular Agents | 1 | 2004 | 867 | 0.040 |
Why?
|
Gadolinium | 1 | 2002 | 959 | 0.040 |
Why?
|
Blood Vessels | 1 | 2002 | 1112 | 0.030 |
Why?
|
Subtraction Technique | 1 | 1980 | 510 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2011 | 20509 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2004 | 1261 | 0.030 |
Why?
|
Prospective Studies | 11 | 2012 | 54303 | 0.030 |
Why?
|
Fibrinolytic Agents | 3 | 1997 | 2167 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 2000 | 424 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2005 | 8950 | 0.030 |
Why?
|
Prognosis | 6 | 2009 | 29658 | 0.030 |
Why?
|
Atrial Fibrillation | 2 | 2005 | 5209 | 0.030 |
Why?
|
Kidney Cortex | 1 | 1976 | 169 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2011 | 4925 | 0.030 |
Why?
|
Pulmonary Artery | 3 | 2000 | 1921 | 0.030 |
Why?
|
Defibrillators, Implantable | 1 | 2005 | 1499 | 0.030 |
Why?
|
Educational Technology | 1 | 1995 | 59 | 0.030 |
Why?
|
ROC Curve | 3 | 2011 | 3568 | 0.030 |
Why?
|
Stem Cells | 1 | 2008 | 3523 | 0.030 |
Why?
|
Young Adult | 3 | 2011 | 58741 | 0.030 |
Why?
|
RNA, Viral | 1 | 2003 | 2838 | 0.030 |
Why?
|
Systole | 3 | 2006 | 947 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2004 | 1894 | 0.030 |
Why?
|
History, 20th Century | 1 | 2003 | 2773 | 0.030 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2002 | 1046 | 0.030 |
Why?
|
Regression Analysis | 2 | 2003 | 6360 | 0.030 |
Why?
|
Iridium | 2 | 1986 | 95 | 0.030 |
Why?
|
Genotype | 2 | 2014 | 12960 | 0.030 |
Why?
|
Research Design | 2 | 2007 | 6180 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2021 | 36290 | 0.030 |
Why?
|
Severity of Illness Index | 5 | 2007 | 15840 | 0.030 |
Why?
|
Tachycardia | 5 | 1991 | 602 | 0.030 |
Why?
|
Acetanilides | 2 | 2004 | 169 | 0.030 |
Why?
|
Valine | 1 | 2014 | 409 | 0.030 |
Why?
|
Probability | 2 | 2006 | 2475 | 0.030 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2002 | 1311 | 0.030 |
Why?
|
Pentetic Acid | 1 | 1992 | 209 | 0.030 |
Why?
|
Keto Acids | 1 | 2012 | 34 | 0.030 |
Why?
|
Peptides | 1 | 2004 | 4354 | 0.030 |
Why?
|
Syncope | 1 | 1995 | 428 | 0.030 |
Why?
|
Positive-Pressure Respiration | 1 | 1996 | 636 | 0.020 |
Why?
|
Ventriculography, First-Pass | 1 | 1991 | 20 | 0.020 |
Why?
|
Mathematics | 2 | 1983 | 707 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 5889 | 0.020 |
Why?
|
Dogs | 5 | 1991 | 3841 | 0.020 |
Why?
|
Patient Selection | 2 | 2001 | 4283 | 0.020 |
Why?
|
Constriction | 1 | 2011 | 172 | 0.020 |
Why?
|
Calcinosis | 1 | 2000 | 1476 | 0.020 |
Why?
|
Mutation | 2 | 2014 | 29932 | 0.020 |
Why?
|
Sex Distribution | 2 | 2007 | 2295 | 0.020 |
Why?
|
Heart Septal Defects | 1 | 1992 | 191 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2002 | 4713 | 0.020 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 1994 | 491 | 0.020 |
Why?
|
Analog-Digital Conversion | 1 | 1990 | 23 | 0.020 |
Why?
|
Mice | 5 | 2004 | 81208 | 0.020 |
Why?
|
Rheology | 1 | 2012 | 348 | 0.020 |
Why?
|
Age Distribution | 2 | 2007 | 2893 | 0.020 |
Why?
|
Diagnosis, Differential | 5 | 2011 | 12965 | 0.020 |
Why?
|
Indium | 1 | 1990 | 46 | 0.020 |
Why?
|
Hyperhomocysteinemia | 1 | 2011 | 118 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2004 | 8056 | 0.020 |
Why?
|
Lung Diseases | 1 | 2000 | 1915 | 0.020 |
Why?
|
Supination | 1 | 1990 | 68 | 0.020 |
Why?
|
Eating | 2 | 1995 | 1539 | 0.020 |
Why?
|
Bone and Bones | 1 | 2000 | 2560 | 0.020 |
Why?
|
Transposition of Great Vessels | 1 | 1994 | 590 | 0.020 |
Why?
|
Case-Control Studies | 5 | 2007 | 22053 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 17624 | 0.020 |
Why?
|
Cardiac Volume | 1 | 1990 | 199 | 0.020 |
Why?
|
Cerebral Hemorrhage | 2 | 1997 | 2660 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2002 | 3598 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2014 | 1167 | 0.020 |
Why?
|
Models, Biological | 2 | 2002 | 9467 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2003 | 12766 | 0.020 |
Why?
|
Technetium Tc 99m Sestamibi | 2 | 2002 | 173 | 0.020 |
Why?
|
Hemorrhage | 2 | 1997 | 3600 | 0.020 |
Why?
|
Survival Analysis | 3 | 2007 | 10182 | 0.020 |
Why?
|
Phenotype | 2 | 2004 | 16546 | 0.020 |
Why?
|
Hyperparathyroidism | 1 | 2009 | 339 | 0.020 |
Why?
|
Airway Obstruction | 1 | 1992 | 662 | 0.020 |
Why?
|
Prevalence | 3 | 2011 | 15687 | 0.020 |
Why?
|
Clinical Competence | 1 | 2003 | 4783 | 0.020 |
Why?
|
Plasminogen Activators | 2 | 1997 | 199 | 0.020 |
Why?
|
Computer Systems | 1 | 1989 | 470 | 0.020 |
Why?
|
Platelet Activation | 1 | 2011 | 660 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2014 | 2192 | 0.020 |
Why?
|
Dyspnea | 2 | 2007 | 1352 | 0.020 |
Why?
|
Hypotension, Orthostatic | 1 | 1990 | 256 | 0.020 |
Why?
|
Nifedipine | 1 | 2007 | 221 | 0.020 |
Why?
|
Area Under Curve | 1 | 2011 | 1636 | 0.020 |
Why?
|
Wisconsin | 1 | 2006 | 122 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 9585 | 0.020 |
Why?
|
Fluorescein Angiography | 1 | 2012 | 1045 | 0.020 |
Why?
|
Pulse | 1 | 1986 | 218 | 0.020 |
Why?
|
DNA, Viral | 2 | 2003 | 2194 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2014 | 3584 | 0.020 |
Why?
|
Linear Models | 2 | 2011 | 5877 | 0.020 |
Why?
|
Papillary Muscles | 1 | 1986 | 192 | 0.020 |
Why?
|
Virus Replication | 2 | 2004 | 2432 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 1983 | 1131 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2021 | 6465 | 0.020 |
Why?
|
Kidney Diseases | 1 | 1976 | 2093 | 0.020 |
Why?
|
Spironolactone | 1 | 2009 | 411 | 0.020 |
Why?
|
Antipyrine | 1 | 1985 | 40 | 0.020 |
Why?
|
Phosphocreatine | 1 | 1985 | 261 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2009 | 10344 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 1985 | 182 | 0.020 |
Why?
|
Reassortant Viruses | 1 | 2004 | 36 | 0.020 |
Why?
|
Nocodazole | 1 | 2004 | 95 | 0.020 |
Why?
|
Lepidoptera | 1 | 2004 | 24 | 0.010 |
Why?
|
Spodoptera | 1 | 2004 | 141 | 0.010 |
Why?
|
Computer Simulation | 1 | 1998 | 6218 | 0.010 |
Why?
|
Baculoviridae | 1 | 2004 | 115 | 0.010 |
Why?
|
Syndrome | 1 | 2011 | 3280 | 0.010 |
Why?
|
Follow-Up Studies | 6 | 2005 | 39261 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 1523 | 0.010 |
Why?
|
Phosphines | 1 | 2003 | 18 | 0.010 |
Why?
|
Radionuclide Ventriculography | 2 | 1994 | 40 | 0.010 |
Why?
|
Telephone | 2 | 1989 | 624 | 0.010 |
Why?
|
Meta-Analysis as Topic | 1 | 2009 | 1376 | 0.010 |
Why?
|
Incidence | 3 | 2007 | 21392 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2011 | 1489 | 0.010 |
Why?
|
Captopril | 1 | 2004 | 265 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2011 | 15289 | 0.010 |
Why?
|
Electrophysiology | 1 | 2006 | 1265 | 0.010 |
Why?
|
Aorta | 1 | 1991 | 2039 | 0.010 |
Why?
|
Genes, Viral | 1 | 2004 | 650 | 0.010 |
Why?
|
Tomography, Spiral Computed | 1 | 2005 | 273 | 0.010 |
Why?
|
Child, Preschool | 4 | 2006 | 42063 | 0.010 |
Why?
|
Angiocardiography | 4 | 1979 | 153 | 0.010 |
Why?
|
Nucleotides | 1 | 1985 | 450 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2003 | 814 | 0.010 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2003 | 106 | 0.010 |
Why?
|
Aging | 2 | 1993 | 8651 | 0.010 |
Why?
|
Brain Neoplasms | 2 | 2002 | 8986 | 0.010 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2003 | 153 | 0.010 |
Why?
|
Jejunal Diseases | 1 | 1983 | 46 | 0.010 |
Why?
|
Equipment Failure | 1 | 2005 | 577 | 0.010 |
Why?
|
Age Factors | 3 | 2009 | 18416 | 0.010 |
Why?
|
Cell Membrane Permeability | 1 | 2004 | 575 | 0.010 |
Why?
|
Hydrolysis | 1 | 2003 | 665 | 0.010 |
Why?
|
Licensure | 1 | 2003 | 128 | 0.010 |
Why?
|
Heart Septum | 1 | 1983 | 303 | 0.010 |
Why?
|
Angiography | 4 | 1997 | 1605 | 0.010 |
Why?
|
Visual Acuity | 1 | 2012 | 2643 | 0.010 |
Why?
|
Neoplasms | 2 | 2003 | 22072 | 0.010 |
Why?
|
Base Sequence | 2 | 2003 | 12446 | 0.010 |
Why?
|
Aortic Aneurysm | 1 | 1986 | 648 | 0.010 |
Why?
|
Comorbidity | 2 | 2007 | 10551 | 0.010 |
Why?
|
Radiology | 1 | 1995 | 2102 | 0.010 |
Why?
|
Inflammation | 2 | 2012 | 10756 | 0.010 |
Why?
|
Safety | 1 | 2006 | 1148 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 2852 | 0.010 |
Why?
|
Homeostasis | 2 | 2009 | 3306 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 1985 | 1032 | 0.010 |
Why?
|
Jejunum | 1 | 1983 | 471 | 0.010 |
Why?
|
Protein Folding | 1 | 2004 | 867 | 0.010 |
Why?
|
Electrodes, Implanted | 1 | 2005 | 833 | 0.010 |
Why?
|
Chelating Agents | 1 | 2002 | 384 | 0.010 |
Why?
|
Tissue and Organ Harvesting | 1 | 2003 | 377 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2003 | 666 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 2003 | 983 | 0.010 |
Why?
|
Graft Occlusion, Vascular | 1 | 2003 | 560 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2004 | 1737 | 0.010 |
Why?
|
Professional Competence | 1 | 2003 | 431 | 0.010 |
Why?
|
Thymus Gland | 1 | 2005 | 1247 | 0.010 |
Why?
|
Heroin | 1 | 2000 | 119 | 0.010 |
Why?
|
Respiration | 1 | 1986 | 1654 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2010 | 2907 | 0.010 |
Why?
|
Organ Size | 1 | 1985 | 2254 | 0.010 |
Why?
|
CHO Cells | 1 | 2002 | 1389 | 0.010 |
Why?
|
Heroin Dependence | 1 | 2000 | 172 | 0.010 |
Why?
|
Methods | 2 | 1987 | 1074 | 0.010 |
Why?
|
Radiology Department, Hospital | 1 | 1983 | 405 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 1976 | 4673 | 0.010 |
Why?
|
Signal Transduction | 1 | 2002 | 23376 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2003 | 2471 | 0.010 |
Why?
|
Adenosine Triphosphate | 2 | 2003 | 1993 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 1976 | 4312 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2006 | 1296 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2003 | 1578 | 0.010 |
Why?
|
Rhabdomyolysis | 1 | 2000 | 155 | 0.010 |
Why?
|
Sleep | 2 | 2006 | 4751 | 0.010 |
Why?
|
Suture Techniques | 1 | 2003 | 790 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10446 | 0.010 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2003 | 741 | 0.010 |
Why?
|
Stress, Physiological | 1 | 1986 | 1398 | 0.010 |
Why?
|
Narcotics | 1 | 2000 | 336 | 0.010 |
Why?
|
False Positive Reactions | 2 | 1994 | 956 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 2006 | 1572 | 0.010 |
Why?
|
Pyridones | 1 | 1983 | 792 | 0.010 |
Why?
|
Child | 4 | 2006 | 79806 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2002 | 1493 | 0.010 |
Why?
|
Temperature | 1 | 2004 | 2221 | 0.010 |
Why?
|
Melena | 1 | 1997 | 32 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 16939 | 0.010 |
Why?
|
Echo-Planar Imaging | 1 | 2002 | 657 | 0.010 |
Why?
|
Corpus Callosum | 1 | 2002 | 749 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2002 | 1077 | 0.010 |
Why?
|
Thorax | 2 | 1994 | 553 | 0.010 |
Why?
|
Partial Thromboplastin Time | 1 | 1997 | 205 | 0.010 |
Why?
|
Rest | 1 | 2002 | 914 | 0.010 |
Why?
|
Mitral Valve Insufficiency | 1 | 1986 | 1419 | 0.010 |
Why?
|
Hemiplegia | 1 | 1997 | 136 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2003 | 2362 | 0.010 |
Why?
|
Risk Factors | 4 | 2011 | 74359 | 0.010 |
Why?
|
Hemangioma | 1 | 1981 | 728 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13314 | 0.010 |
Why?
|
Cineangiography | 2 | 1987 | 113 | 0.010 |
Why?
|
Hematuria | 1 | 1997 | 233 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9276 | 0.010 |
Why?
|
Hematocrit | 1 | 1997 | 629 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2003 | 2943 | 0.010 |
Why?
|
Information Systems | 1 | 1997 | 398 | 0.010 |
Why?
|
Splanchnic Circulation | 1 | 1995 | 110 | 0.010 |
Why?
|
Risk Assessment | 2 | 2007 | 24123 | 0.010 |
Why?
|
Binding Sites | 1 | 2003 | 6048 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2004 | 2061 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 3735 | 0.010 |
Why?
|
Swine | 1 | 2003 | 5899 | 0.010 |
Why?
|
Pneumonectomy | 1 | 2000 | 1111 | 0.010 |
Why?
|
Consensus | 1 | 2003 | 3113 | 0.010 |
Why?
|
Graft Survival | 1 | 2003 | 3794 | 0.010 |
Why?
|
Heart Function Tests | 1 | 1973 | 319 | 0.010 |
Why?
|
Blood Volume Determination | 1 | 1972 | 41 | 0.010 |
Why?
|
Serum Albumin | 2 | 1973 | 674 | 0.010 |
Why?
|
Computer-Assisted Instruction | 1 | 1995 | 362 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 12531 | 0.010 |
Why?
|
Isoproterenol | 1 | 1972 | 394 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1997 | 1722 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2003 | 3486 | 0.010 |
Why?
|
Catheterization | 1 | 1997 | 1432 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2003 | 13451 | 0.010 |
Why?
|
Recurrence | 2 | 1997 | 8482 | 0.010 |
Why?
|
Drinking | 1 | 1993 | 199 | 0.010 |
Why?
|
Confidence Intervals | 1 | 1997 | 2932 | 0.010 |
Why?
|
Consciousness | 1 | 1997 | 602 | 0.010 |
Why?
|
Electrocardiography, Ambulatory | 1 | 1994 | 578 | 0.010 |
Why?
|
Propranolol | 1 | 1972 | 489 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1996 | 1440 | 0.010 |
Why?
|
Graft Rejection | 1 | 2003 | 4426 | 0.010 |
Why?
|
Visual Fields | 1 | 1997 | 1054 | 0.010 |
Why?
|
Vision Disorders | 1 | 1997 | 1084 | 0.010 |
Why?
|
Random Allocation | 1 | 1994 | 2394 | 0.010 |
Why?
|
Patient Admission | 1 | 1997 | 1386 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1976 | 1501 | 0.010 |
Why?
|
Infant | 2 | 2006 | 36060 | 0.010 |
Why?
|
Pregnancy | 1 | 2010 | 29749 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2004 | 18957 | 0.000 |
Why?
|
Biopsy | 1 | 2000 | 6771 | 0.000 |
Why?
|
Evaluation Studies as Topic | 2 | 1982 | 1628 | 0.000 |
Why?
|
Publishing | 1 | 1995 | 836 | 0.000 |
Why?
|
Heart Atria | 2 | 1984 | 1346 | 0.000 |
Why?
|
Biometry | 1 | 1991 | 559 | 0.000 |
Why?
|
Cohort Studies | 1 | 2011 | 41335 | 0.000 |
Why?
|
Acute Kidney Injury | 1 | 2000 | 1941 | 0.000 |
Why?
|
Hospital Information Systems | 1 | 1990 | 394 | 0.000 |
Why?
|
Chi-Square Distribution | 1 | 1994 | 3465 | 0.000 |
Why?
|
Asthma | 1 | 1986 | 6172 | 0.000 |
Why?
|
Glioblastoma | 1 | 2002 | 3484 | 0.000 |
Why?
|
Hemothorax | 1 | 1986 | 57 | 0.000 |
Why?
|
Synovial Membrane | 1 | 1990 | 524 | 0.000 |
Why?
|
Radionuclide Generators | 1 | 1986 | 12 | 0.000 |
Why?
|
Drug Combinations | 1 | 1992 | 2025 | 0.000 |
Why?
|
Fibrin | 1 | 1988 | 505 | 0.000 |
Why?
|
Fibrinogen | 1 | 1988 | 886 | 0.000 |
Why?
|
Nucleosides | 1 | 1985 | 131 | 0.000 |
Why?
|
Cardiomegaly | 1 | 1987 | 593 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2003 | 20080 | 0.000 |
Why?
|
Monitoring, Physiologic | 1 | 1972 | 1784 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1986 | 15697 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 1997 | 12159 | 0.000 |
Why?
|
Vital Capacity | 1 | 1986 | 965 | 0.000 |
Why?
|
Hospital Mortality | 1 | 1997 | 5425 | 0.000 |
Why?
|
Milrinone | 1 | 1983 | 86 | 0.000 |
Why?
|
Cost-Benefit Analysis | 2 | 1989 | 5508 | 0.000 |
Why?
|
Phenylephrine | 1 | 1984 | 293 | 0.000 |
Why?
|
Pressure | 1 | 1986 | 1156 | 0.000 |
Why?
|
Technology, Radiologic | 1 | 1983 | 160 | 0.000 |
Why?
|
Survival Rate | 1 | 1997 | 12808 | 0.000 |
Why?
|
Splenic Rupture | 1 | 1982 | 26 | 0.000 |
Why?
|
Pubic Bone | 1 | 1982 | 31 | 0.000 |
Why?
|
Electricity | 1 | 1983 | 182 | 0.000 |
Why?
|
Drug Evaluation | 1 | 1983 | 641 | 0.000 |
Why?
|
Osteoarthritis | 1 | 1990 | 1055 | 0.000 |
Why?
|
Cranial Fossa, Posterior | 1 | 1982 | 135 | 0.000 |
Why?
|
Accidental Falls | 1 | 1990 | 1056 | 0.000 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 1981 | 63 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2003 | 25942 | 0.000 |
Why?
|
Anticoagulants | 1 | 1997 | 4897 | 0.000 |
Why?
|
Injections, Intravenous | 1 | 1983 | 1385 | 0.000 |
Why?
|
Data Display | 1 | 1981 | 174 | 0.000 |
Why?
|
Gallbladder | 1 | 1982 | 305 | 0.000 |
Why?
|
Sulfur | 1 | 1981 | 163 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1985 | 2502 | 0.000 |
Why?
|
Diverticulitis, Colonic | 1 | 1982 | 138 | 0.000 |
Why?
|
Sacrum | 1 | 1982 | 277 | 0.000 |
Why?
|
Esophagus | 1 | 1986 | 1023 | 0.000 |
Why?
|
Photography | 1 | 1983 | 530 | 0.000 |
Why?
|
Aorta, Thoracic | 1 | 1986 | 1097 | 0.000 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1983 | 461 | 0.000 |
Why?
|
Stress, Mechanical | 1 | 1984 | 1666 | 0.000 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 1983 | 707 | 0.000 |
Why?
|
Electroencephalography | 1 | 1992 | 6189 | 0.000 |
Why?
|
Nitrogen Radioisotopes | 1 | 1976 | 41 | 0.000 |
Why?
|
Oxygen Radioisotopes | 1 | 1976 | 75 | 0.000 |
Why?
|
Perfusion | 1 | 1981 | 1376 | 0.000 |
Why?
|
Vestibulocochlear Nerve | 1 | 1976 | 115 | 0.000 |
Why?
|
Algorithms | 1 | 1996 | 13981 | 0.000 |
Why?
|
Spine | 1 | 1982 | 1111 | 0.000 |
Why?
|
Ammonia | 1 | 1976 | 236 | 0.000 |
Why?
|
Internship and Residency | 1 | 1995 | 5870 | 0.000 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 1976 | 133 | 0.000 |
Why?
|
United States | 1 | 2003 | 72461 | 0.000 |
Why?
|
Cineradiography | 1 | 1973 | 22 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1994 | 26181 | 0.000 |
Why?
|
Embolization, Therapeutic | 1 | 1982 | 1413 | 0.000 |
Why?
|
Astrocytoma | 1 | 1976 | 775 | 0.000 |
Why?
|
Neurilemmoma | 1 | 1976 | 523 | 0.000 |
Why?
|
Pain | 1 | 1984 | 5066 | 0.000 |
Why?
|
Meningioma | 1 | 1976 | 1221 | 0.000 |
Why?
|
Mitral Valve | 1 | 1973 | 1486 | 0.000 |
Why?
|
Aortic Valve | 1 | 1973 | 1996 | 0.000 |
Why?
|
Glioma | 1 | 1976 | 3420 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 1976 | 6315 | 0.000 |
Why?
|